# Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

> **NCT03083353** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Texas at Austin** · enrollment: 78 (actual)

## Conditions studied

- Nicotine Dependence
- Smoking, Cigarette
- Smoking Cessation
- Smoking Behaviors
- Smoking Reduction
- Craving

## Interventions

- **DRUG:** Isradipine
- **BEHAVIORAL:** Cue Exposure

## Key facts

- **NCT ID:** NCT03083353
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-22
- **Primary completion:** 2023-06-14
- **Final completion:** 2023-06-14
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03083353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03083353, "Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03083353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*